BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29397771)

  • 1. Dual HIV-1 reverse transcriptase and integrase inhibitors from
    Sanna C; Rigano D; Corona A; Piano D; Formisano C; Farci D; Franzini G; Ballero M; Chianese G; Tramontano E; Taglialatela-Scafati O; Esposito F
    Nat Prod Res; 2019 Jun; 33(12):1798-1803. PubMed ID: 29397771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Hydroxypyrido[2,3-b]pyrazin-6(5H)-one derivatives as novel dual inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H and integrase.
    Sun L; Gao P; Dong G; Zhang X; Cheng X; Ding X; Wang X; Daelemans D; De Clercq E; Pannecouque C; Menéndez-Arias L; Zhan P; Liu X
    Eur J Med Chem; 2018 Jul; 155():714-724. PubMed ID: 29940462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship of pyrrolyl diketo acid derivatives as dual inhibitors of HIV-1 integrase and reverse transcriptase ribonuclease H domain.
    Cuzzucoli Crucitti G; Métifiot M; Pescatori L; Messore A; Madia VN; Pupo G; Saccoliti F; Scipione L; Tortorella S; Esposito F; Corona A; Cadeddu M; Marchand C; Pommier Y; Tramontano E; Costi R; Di Santo R
    J Med Chem; 2015 Feb; 58(4):1915-28. PubMed ID: 25629256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uvaria angolensis as a promising source of inhibitors of HIV-1 RT-associated RNA-dependent DNA polymerase and RNase H functions.
    Ngoutane Mfopa A; Corona A; Eloh K; Tramontano E; Frau A; Boyom FF; Caboni P; Tocco G
    Nat Prod Res; 2018 Mar; 32(6):640-647. PubMed ID: 28540745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase.
    Wang Z; Tang J; Salomon CE; Dreis CD; Vince R
    Bioorg Med Chem; 2010 Jun; 18(12):4202-11. PubMed ID: 20576573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 integrase and RNase H activities as therapeutic targets.
    Andréola ML; De Soultrait VR; Fournier M; Parissi V; Desjobert C; Litvak S
    Expert Opin Ther Targets; 2002 Aug; 6(4):433-46. PubMed ID: 12223059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in rationally designed dual inhibitors of HIV-1 reverse transcriptase and integrase.
    Gu SX; Xue P; Ju XL; Zhu YY
    Bioorg Med Chem; 2016 Nov; 24(21):5007-5016. PubMed ID: 27658796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the DNA polymerase and RNase H activities of HIV-1 reverse transcriptase and HIV-1 replication by Brasenia schreberi (Junsai) and Petasites japonicus (Fuki) components.
    Hisayoshi T; Shinomura M; Yokokawa K; Kuze I; Konishi A; Kawaji K; Kodama EN; Hata K; Takahashi S; Nirasawa S; Sakuda S; Yasukawa K
    J Nat Med; 2015 Jul; 69(3):432-40. PubMed ID: 25663480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diketo acids derivatives as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H domain.
    Di Santo R
    Curr Med Chem; 2011; 18(22):3335-42. PubMed ID: 21728968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Docking and Molecular Dynamics Simulation Based Approach to Explore the Dual Inhibitor Against HIV-1 Reverse Transcriptase and Integrase.
    Chander S; Pandey RK; Penta A; Choudhary BS; Sharma M; Malik R; Prajapati VK; Murugesan S
    Comb Chem High Throughput Screen; 2017; 20(8):734-746. PubMed ID: 28641512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of selected South African medicinal plants for inhibitory properties against human immunodeficiency virus type 1 reverse transcriptase and integrase.
    Bessong PO; Obi CL; Andréola ML; Rojas LB; Pouységu L; Igumbor E; Meyer JJ; Quideau S; Litvak S
    J Ethnopharmacol; 2005 May; 99(1):83-91. PubMed ID: 15848024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the glycosyl moiety of myricetin derivatives in anti-HIV-1 activity in vitro.
    Ortega JT; Suárez AI; Serrano ML; Baptista J; Pujol FH; Rangel HR
    AIDS Res Ther; 2017 Oct; 14(1):57. PubMed ID: 29025433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavonoids and Acid-Hydrolysis derivatives of
    Fois B; Corona A; Tramontano E; Distinto S; Maccioni E; Meleddu R; Caboni P; Floris C; Cottiglia F
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):749-757. PubMed ID: 33715562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of HIV-1 reverse transcriptase and integrase dual inhibitors: Recent advances and developments.
    Gill MSA; Hassan SS; Ahemad N
    Eur J Med Chem; 2019 Oct; 179():423-448. PubMed ID: 31265935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of novel lipid-functionalized PNA monomers as potential HIV-1 non-nucleoside reverse transcriptase and/or integrase inhibitors.
    Thomas MG; Maga G; Mouscadet JF; Howarth NM
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1063-6. PubMed ID: 18058537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory activity on HIV-1 reverse transcriptase and integrase of a carmalol derivative from a brown Alga, Ishige okamurae.
    Ahn MJ; Yoon KD; Kim CY; Kim JH; Shin CG; Kim J
    Phytother Res; 2006 Aug; 20(8):711-3. PubMed ID: 16775811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavanone and flavonol glycosides from the leaves of Thevetia peruviana and their HIV-1 reverse transcriptase and HIV-1 integrase inhibitory activities.
    Tewtrakul S; Nakamura N; Hattori M; Fujiwara T; Supavita T
    Chem Pharm Bull (Tokyo); 2002 May; 50(5):630-5. PubMed ID: 12036017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of HIV-1 reverse transcriptase and integrase: classical and emerging therapeutical approaches.
    Tarrago-Litvak L; Andreola ML; Fournier M; Nevinsky GA; Parissi V; de Soultrait VR; Litvak S
    Curr Pharm Des; 2002; 8(8):595-614. PubMed ID: 11945161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human immunodeficiency virus type 1 reverse transcriptase and ribonuclease H activities by constituents of Juglans mandshurica.
    Min BS; Nakamura N; Miyashiro H; Kim YH; Hattori M
    Chem Pharm Bull (Tokyo); 2000 Feb; 48(2):194-200. PubMed ID: 10705503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).
    Gleenberg IO; Herschhorn A; Hizi A
    J Mol Biol; 2007 Jun; 369(5):1230-43. PubMed ID: 17490682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.